Open Journal Systems

Cover Image

Modeling and docking analysis of GPR87 with anti-cancer drugs

Mukta Rani, Anuradha Nischal, Ganesh Chandra Sahoo, Sanjay Khattri


Orphan G-protein coupled receptor 87 (GPR87) in human is a very recently discovered orphan GPCR means that the search for their endogenous ligands has been a challenge. GPR87 was shown to be over expressed in squamous cell carcinoma (SCCs) or adenocarcinoma in the lung and bladder carcinomas. We have predicted the comparative account on 3Dstructures of GPR87 on the basis of PDB ID: 3ODU|A. The model was further validated by comparison with structural features of the template proteins by using Verify-3D,ProSA and ERRAT servers were used for determining the stereo-chemical parameters of 3D structure of GPR87 predicted by Ramachandran plot and good 3-D structure compatibility as assessed by DOPE score.  Molecular dynamics (MD) simulation of models is studied of protein by conjugate gradient method. The DRY-motif (Asp- Arg-Tyr sequence) at the end of helix 3 is highlighted, where the G-protein binds and thus the activation signals are transduced. Protein-ligand interactions shows highest dock score with doxorubicin is 96.654, and involved binding site residues of GPR87 are Phe67, Lys247, Lys249, Asn330 and Asp357. In search for a better inhibitor for GPR87, insilico modification of some anti-cancer ligands shows doxorubicin has shown the highest binding affinity with GPR87. So our study provides an early insight into the structure of major drug target GPR87, thus facilitating the inhibitor design.


GPCR, GPR87, Modeling, Docking, Anti-cancer. Modeling: Docking.

Full Text:



Hans BO, Petrine W, Anders AJ: Structure, Pharmacology and Therapeutic Prospects of Family C G-Protein Coupled Receptors. Current Drug Targets 2007, 8: 169-184.

Shore DM, Reggio PH: The therapeutic potential of orphan GPCRs, GPR35 and GPR55. Front Pharmacol. 2015, 15: 6-69.

Tabata K, Baba K, Shiraishi A, Ito M, Fujita N: The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor. Biochem.Biophys. Res. Commun 2007, 363: 861-866.

Gugger M, White R, Song S: GPR87 is an over expressed G-protein coupled receptor in squamous cell carcinoma of the lung. Dis Markers 2008, 24: 41–50.

Pierce KL, Premont RT, Lefkowitz RJ: Seven-transmembrane receptors. Nat Rev Mol Cell Biol 2002, 3: 639-650.

Nonaka Y, Hiramoto H, Fujita N: Identification of endogenous surrogate ligands for human P2Y12 receptors by in silico and in vitro methods. Biochem. Biophys. Res. Commun 2005, 337: 281-288.

Wittenberger T, Schaller HC, Hellebrand S: An expressed sequence tag (EST) data mining strategy succeeding in the discovery of new Gprotein coupled receptors. J Mol Biol 2001, 307: 799-813.

Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. J Mol. Biol 1990, 215(3): 403–410.

Arnold K, Bordoli L, Kopp J, Schwede T: The SWISS-MODEL workspace: a web-based environment for protein structure homology modeling. Bioinformatics 2006, 22: 195-201.

Wu B, Chien EY, Mol CD, et al.: Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists. Science 2010, 330(6007): 1066-1071.

Laskowski RA, MacArthur MW, Moss DS, Thornton JM: PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Cryst 1993, 26: 283-291.

Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, Karplus M: CHARMM: a program for macromolecular energy minimization and dynamics calculations. J Comput Chem 1993, 4: 187–217.

Accelrys Software Inc., Cerius2 Modeling Environment, Release 4.7, Accelrys Software Inc., San Diego, 2003.

Rani M, Nischal A, Sahoo, GC, Khattri, S: Computational Analysis of the 3-D structure of Human GPR87 Protein: Implications for Structure-Based Drug Design. Asian Pac J Cancer Prev 2013, 14 (12): 7473-7482.

Zhang Z, Li Y, Lin B, Schroeder M, Huang B: Identification of cavities on protein surface using multiple computational approaches for drug binding site prediction. Bioinformatics 2011, 27(15): 2083-2088.

Dundas J, Ouyang Z, Tseng J, Binkowski A, Turpaz Y, Liang J: CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acid Research 2006, 34: 116-118.

Venkatachalam CM, Jiang X, Oldfield T, Waldman M: LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. J Mol Graphics Modelling 2003, 21: 289–307.

Mayo SL, Olafson BD, Goddard WA III: Dreiding: ageneric force forcefield for molecular simulation. J Phys Chem 1990, 94: 8897–8909.

Lipinski CA: Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 2001, 44: 235–249.

Lipinski CA, Lombardo F, Dominy BW, Feeney JP: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development setting. Adv Drug Deliv Rev 2001, 46: 3–26.



  • There are currently no refbacks.